Acute Liver Failure (ALF)
Definition:
Pediatric Acute Liver Failure Study Group (PALF) Defines ALF as:
- Biochemical evidence of Liver Injury
- no known h/o chronic liver disease
- Coagulopathy not due to vit K deficiency (not corrected by Vit K)
- INR > 1.5 if the patient has hepatic encephalopathy or >2.0
without encephalopathy
Adult definition is hepatic encephalopathy and coagulopathy within 8wks
of onset of liver disease
Etiology
Age 0-3 (unknown in 50%, Metabolic 15%, Viral 8%, autoimmune 4%,
Ischemia 4%, Tylenol 3%, Drugs 0.5%, other 12%)
Age 3-18 (unknown 50%, Tylenol 18%, Autoimmune 8%, metabolic 7%,
other 7%, drugs 6%, ischemia 4%)
- Toxins and Meds
- Acetaminophen (3% of cases ages 0-3, 18% of cases ages 3-18)
- Diagnosis: Toxic level on Rumack nomogram or >100mg/kg w/i
24hr period
- High aminotransferase levels with relatively low bili level
- Chronic use can also lead to hepatotoxicity
- Tx: N-Acetylcysteine (mucomyst)
- Anticonvulsants (phenytoin, carbamazepine, valproic acid)
- May see rash, fever, eosinophilia
- Mushroom poisoning
- Isoniazid
- Amiodarone
- Ecstasy
- Metabolic
- Wilson Disease (Cu accumulation) also known as hepatolenticular
degeneration
- AR mutation in ATP7B gene
- Serum ceruloplasmin may be normal in ALF
- Very Low Alk phos, High bili/Alk Phos ratio, hemolytic anemia
- Poor prognosis without transplantation
- Galactosemia (body cannot convert galactose to glucose)
- positive urine-reducing substances in patient consuming
lactose containing formula
- if Classic form not treated with low galactose diet, lifr
threatiening complications develop w/i a few days of birth
- feeding difficulties, lethargy, FTT, jaundice, liver
failure, cateracts, dev delay
- Gram-negative sepsis (E.Coli), shock
- Hereditary Fructose intolerance
- unable to tolerate introduction of fruit/sucrose
- note: some meds are in sucrose suspension
- Tyrosenemia
- Profound coagulopathy
- normal / near normal aminotransferases
- Gram negative sepsis
- Urea cycle defect
- Very high levels of NH3 without acidosis
- Ornithine transcarbamylase deficiency most common (x-linked)
- Fatty Acid Oxidation (FAO) defects (e.g. MCAD
- hypoketotic hypoglycemia
- reye-like syndrome
- Mitochondrial disorders
- Elevated lactate:pyruvate ratio >20
- Note: Metabolic conditions affecting children within the first month of life include:
galactosemia, tyrosinemia, Niemann-pick type C, mitochondrial
hepatopathies, and urea cycle defects
- <6mo:
- galactosemia
- niemann pick type C
- tyrosinemia
- glycosylation defect
- mitochondrial disease
- 7mo-4yrs:
- Mitochondrial disease
- Tyrosinemia
- A1AT deficiency
- hereditary fructose intolerance
- urea cycle defects
- 5 -18 yrs
- Wilson disease
- mitochondrial disease
- fatty liver of pregnancy
- Immune
- Autoimmune Hepatits (AIH)
- Hematophagocytic lymphohistiocytosis
- Gestational Alloimmune liver disease (previously called
neonatal hemochromatosis)
- Infections
- Hep A and E are the most common cause of ALF in endemic areas
- HSV
- HHV6
- VZV
- CMV
- EBV
- Adenovirus, Dengue, enterovirus family
- Ischemia
- Shock
- Budd-Chiari (blockage of hepatic veins resulting in backup of
blood in liver)
- Congenital Heart Disease
- Cardiac Surgery
- Malignancy
Presentation: (Varies based on
etiology)
- Typically healthy patient with flu-like prodrome, malaise,
mylalgia, nausea, vomiting, jaundice
- Jaundice is typically a late feature
Diagnostic Testing (varies based on
presentation)
- HFP or CMP with direct bili
- PTT/INR
- CBC
- Type and screen
- Tox screen
- Acetaminophen level
- Viral Hepatits serologies (acute/chronic hep panels)
- Ceruloplasmin
- Pregnancy Test
- Ammonia (arterial if possible, free flowing venous sample placed
on ice may be acceptable. for specific handleing and collection - check
with local lab)
- Autoimmune tests
- ANA
- Anti-SMA
- Anti LKM
- IgG level
- Plasma Amino Acids
- Urine Organic Acids
- Acylcarnitine profile
- Enzyme testing
- Liver Biopsy
- Imaging (Cancer, Budd Chiari)
- Genetics
- Amylase / lipase
Age prioritized workup
< 3 months of age
- Herpes blood PCR (or other testing: HSV IgM, viral culture of
blood or CSF, CSF PCR)
- Enterovirus blood PCR (or other testing)
- Lactate, pyruvate (mitochondrial screen)
- Plasma acylcarnitine profile (fatty acid oxidation defects)
- Ferritin (neonatal iron storage disease screen)
- Serum amino acid profile (urea cycle and metabolic)
- Echocardiography (cardiac dysfunction)
- Abdominal ultrasound with Doppler (vascular and anatomic
dysfunction)
- Confirm newborn screen results (galactosemia)
- Confirm maternal hepatitis B serology
3 months to 4 years
- HBsAg, HAV IgM, EBV (VCA IgM or EBV PCR)
- Lactate, pyruvate (mitochondrial screen)
- Autoimmune markers: ANA, ASMA, ALKM, IgG
- Drug history, acetaminophen level
- Plasma acylcarnitine profile (fatty acid oxidation defects)
- Serum amino acids
- Abdominal ultrasound with Doppler (vascular and anatomic)
5 years to 18 years
- HBsAg, HAV IgM, EBV (EBV VCA IgM or PCR)
- Autoimmune markers: ANA, ASMA, ALKM, IgG
- Ceruloplasmin
- Drug history, acetaminophen level
- Lactate, pyruvate (mitochondrial screen)
- Plasma acylcarnitine profile (fatty acid oxidation defects)
- Serum amino acids
- Abdominal ultrasound with Doppler (vascular and anatomic)
Additional diagnostic screening tests
to consider directed by
history and clinical course
- Infectious causes:
- blood culture
- viral PCR in blood for adenovirus, enterovirus, EBV, human
herpesvirus 6, parvovirus
- nasal wash for influenza (infections)
- hepatitis E antibody
- Soluble interleukin-2 receptor, ferritin in older patients,
triglycerides (hemophagocytic lymphohistiocytosis)
- Echocardiography (cardiac)
- MRI for tissue iron (neonatal iron storage)
- Urine succinyl acetone (tyrosinemia)
- Urine orotic acid (urea cycle defects)
- Urine organic acids (metabolic)
- Liver copper, Wilson gene mutation analysis (Wilson disease)
- Liver biopsy for histology, culture, electron microscopy
Treatment
- Patients with ALF should be hospitalized and monitored
frequently, preferably in an ICU
- Early consultation with Liver Tranplant center with plans to
transfer care as soon as possible
- Etiology should be determined to guide further management
decisions (treat primary etiology if known)
- Specific considerations/complications
- 1. Acetaminophen → N-acetylcysteine
- 2. Drug-induced → remove offending drug
- 3. Galactosemia → remove dietary lactose
- 4. Tyrosinemia → NTBC
(2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione)
- 5. FAO defects → IV glucose and avoid fasting
- 6. Wilson disease → liver transplantation
- 7. AIH → corticosteroids
- 8. Herpes → acyclovir; also consider if suspected HSV
- 9. Neonatal hemochromatosis → IV immunoglobulin (IVIG) and
plasmapheresis; IVIG in future pregnancies
Supportive care
- Consider transfer to a center able to provide liver transplant
- Manage ICP and multiorgan failure while awaiting recovery of
liver function or liver transplant
- Maintain adequate glucose infusion rate
- Electrolyte replacement (correct hypokalemia and
hypophosphatemia)
- Encephalopathy: medical therapy with lactulose. Minimize
sedation, treat sepsis, and lower protein intake. ICP monitoring is
controversial. Consider mannitol, hyperventilation, hypothermia, or
barbiturate coma for cerebral edema.
- Coagulopathy: correct prothrombin time (PT)/INR with fresh frozen
plasma or recombinant factor VII only in the setting of active bleeding
or in anticipation of an invasive procedure
- Prophylactic acid-suppressive therapy
- Patients may develop hepatorenal syndrome or acute tubular
necrosis and require dialysis or continuous veno-venous hemofiltration
- Obtain blood cultures and start antibiotics if indicated (↑
susceptibility to infections)
Cerebral
Edema/Intracranial Hypertension
Grade I/II Encephalopathy
-Consider transfer to liver transplant facility and listing for
transplantation
-Brain CT: rule out other causes
of decreased mental status; little
utility to identify cerebral edema
-Avoid stimulation; avoid sedation if possible
-Antibiotics: surveillance and treatment of infection required;
prophylaxis possibly helpful
-Lactulose, possibly helpful
Grade III/IV Encephalopathy
-Continue management strategies listed above
-Intubate trachea (may require sedation)
-Elevate head of bed
-Consider placement of ICP monitoring device
-Immediate treatment of seizures required; prophylaxis of unclear value
-Mannitol: use for severe elevation of ICP or first clinical signs of
herniation
-Hypertonic saline to raise serum sodium to 145-155 mmol/L
-Hyperventilation: effects short-lived; may use for impending herniation
Infection
-Surveillance for and prompt antimicrobial treatment of infection
required (obtain cultures for any clinical deterioration - fever
may not be present)
-Antibiotic prophylaxis possibly helpful but not proven
Coagulopathy (decrease in both
procoagulant proteins V,VII,X, and fibrinogen and anticoagulant
antithrombin, proteins C&S)
-Bleeding is actually relatively rare complication
-Vitamin K: give at least one dose
-FFP: give only for invasive procedures or active bleeding
-Platelets: give only for invasive procedures or active bleeding
-Recombinant activated factor VII: possibly effective for invasive
procedures
-Prophylaxis for stress ulceration: give H2blocker or PPI
Aplastic Anemia
-immunomodulatory medications (corticosteroids, cyclosporine A,
etc...)
-hematopoetic stem cell transplantation
Hemodynamics/Renal Failure
-Volume replacement
-Pressor support (dopamine, epinephrine, norepinephrine) as
needed to maintain adequate mean arterial pressure
-Avoid nephrotoxic agents
-Continuous modes of hemodialysis if needed
-Vasopressin recommended in hypotension refractory to
volume resuscitation and norepinephrine
Ascites
-Can develop in some patients with hypoalbuminemia and excessive fluid
administration
-restrict fluid
-diuretics reserved for patients with respiratoryt compromise or
generalized fluid overload (aggressive diuresis may lead to hepatorenal
syndrome)
Metabolic Concerns
-Follow closely: glucose, potassium, magnesium, phosphate
-Consider nutrition: enteral feedings if possible or total parenteral
nutrition
Detox
plasmapheresis/plasma exchange may be needed to remove suspected toxins
from the blood
Liver Transplant
- Pediatric ALF (PALF) results in death or liver transplantation in
up to 45% of pediatric patients
- Patients with ALF are more likely to be critically ill at the
time of transplant than most end-stage liver disease recipients and may
die from multisystem organ failure or neurologic complicationsa.
Studies show 1-year survival of 80%–90% after liver transplantation
- Several scoring systems help predict PALF outcome and the need to
proceed with transplantation
- The liver injury unit (LIU) scoring system, with LIU = [3.584
× peak total bilirubin (mg/dL)] + [1.809 × peak PT
(seconds)] + [0.307 × peak NH3 ammonia (μmol/L)], was found
by the PALF study group to be a better predictor of transplant-free
survival than other scoring systems. However, making the decision to
move forward with transplantation still remains challenging.
- In general, progressive encephalopathy, worsening coagulopathy,
and worsening cholestasis associated with poor outcome of the native
liver
----------------------------------------
Grades of Encephalopathy
I - Changes in behavior with minimal change in level of
consciousness
II - Gross disorientation, drowsiness, possibly asterixis,
inappropriate behavior
III - Marked confusion; incoherent speech, sleeping most of the time
but arousable to vocal stimuli
IV - Comatose, unresponsive to pain, decorticate or decerebrate
posturing